Skip to main content

Research Repository

Advanced Search

A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke

Wong, Raymond; Pradillo, Jesus M.; Denes, Adam; Dhungana, Hiramani; Malm, Tarja; Koistinaho, Jari; Orset, Cyrille; Rahman, Mahbubur; Rubio, Marina; Schwaninger, Markus; Vivien, Denis; Bath, Philip M.; Rothwell, Nancy J.; Allan, Stuart M.; Maysami, S

A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke Thumbnail


Authors

Raymond Wong

Jesus M. Pradillo

Adam Denes

Hiramani Dhungana

Tarja Malm

Jari Koistinaho

Cyrille Orset

Mahbubur Rahman

Marina Rubio

Markus Schwaninger

Denis Vivien

Philip M. Bath

Nancy J. Rothwell

Stuart M. Allan



Abstract

Stroke represents a global challenge and is a leading cause of permanent disability worldwide. Despite much effort, translation of research findings to clinical benefit has not yet been successful. Failure of neuroprotection trials is considered, in part, due to the low quality of preclinical studies, low level of reproducibility across different laboratories and that stroke co-morbidities have not been fully considered in experimental models. More rigorous testing of new drug candidates in different experimental models of stroke and initiation of preclinical cross-laboratory studies have been suggested as ways to improve translation. However, to our knowledge, no drugs currently in clinical stroke trials have been investigated in preclinical cross-laboratory studies. The cytokine interleukin 1 is a key mediator of neuronal injury, and the naturally occurring interleukin 1 receptor antagonist has been reported as beneficial in experimental studies of stroke. In the present paper, we report on a preclinical cross-laboratory stroke trial designed to investigate the efficacy of interleukin 1 receptor antagonist in different research laboratories across Europe. Our results strongly support the therapeutic potential of interleukin 1 receptor antagonist in experimental stroke and provide further evidence that interleukin 1 receptor antagonist should be evaluated in more extensive clinical stroke trials.

Journal Article Type Article
Acceptance Date Jul 21, 2015
Publication Date Sep 30, 2015
Publicly Available Date May 26, 2023
Journal JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Print ISSN 0271-678X
Publisher SAGE Publications
Volume 36
Issue 3
Pages 596-605
DOI https://doi.org/10.1177/0271678X15606714
Keywords Acute stroke; inflammation; animal models; neuroprotection; experimental
Publisher URL https://journals.sagepub.com/doi/10.1177/0271678X15606714

Files







You might also like



Downloadable Citations